Teva, Takeda form Japanese generics JV

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) formed a joint venture to market Teva's generics and Takeda's off-patent drugs in Japan. Teva and Takeda will split ownership 51-49%.

The partners said the venture will combine Teva's generics portfolio with Takeda's distribution network and brand recognition, adding that the business model is consistent with the Japanese government's push to limit health care spending by increasing market penetration for generics. ...